Stories about Genetik

nal von minden GmbH

New: Combined rapid test for Covid-19 and influenza

EvoBiotiX

EvoBiotiX collaborates with Boehringer Ingelheim and the University of Salzburg on naturally derived Extracellular Vesicles (EVs)

Salzburg/Melide(CH) (ots) - Swiss Biotech EvoBiotiX SA today announced a multi-year collaboration with Boehringer Ingelheim in the field of naturally derived EVs. A significant part of this program will fund research of the drug delivery potential of naturally derived EVs in the group of Prof. Meisner-Kober at the ...

Technische Universität München

A molecular break for root growth - Length of plant roots is controlled by hormones

Corporate Communications Center phone: +49 8161 5403 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36257/ Images for journalists: https://mediatum.ub.tum.de/1576953 NEWS RELEASE Length of plant roots is controlled by hormones A molecular break for root growth The dynamic change in root ...

Fördergesellschaft IZB mbH

2

Proteintech Acquires ChromoTek, Expanding its Next Generation Antibody Tools

Technische Universität München

Coronavirus: door opener facilates cell entry

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 22562 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36263/ NEWS RELEASE How the virus enters the cell Coronavirus: Neuropilin-1 could open the door to the inside of the cell The protein neuropilin-1 facilitates SARS CoV-2 cell entry. A research team including ...

Technische Universität München

Fighting corona with machine learning

Corporate Communications Center phone: +49 8161 5403 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36254/ NEWS RELEASE The Bavarian Research Foundation is funding five TUM-research projects on Covid-19 Fighting corona with machine learning The Technical University of Munich (TUM) is starting five new research projects that focus on the ...

Technische Universität München

An alternative to animal experiments - New applications for organoids from human intestinal tissue

Corporate Communications Center phone: +49 8161 5403 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36252/ Images for journalists: https://mediatum.ub.tum.de/1576619 NEWS RELEASE New applications for organoids from human intestinal ...

Technische Universität München

Intelligent software for a better understanding of plant tissue development

Corporate Communications Center phone: +49 8161 5403 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36238/ Images for journalists: https://mediatum.ub.tum.de/1575701 NEWS RELEASE Intelligent software for a better understanding of plant tissue development 3D images display plant organs down ...

Sysmex Inostics GmbH

Sysmex Inostics' Liquid Biopsy Testing Benefits Metastatic Pancreatic Cancer Patient Management

Baltimore, MD (ots) - Sysmex Inostics, Inc., a global leader and pioneer in blood-based circulating cell-free tumor DNA (ctDNA) analysis for oncology, today announces the publication of a clinical study investigating the utility of cfDNA-based markers using the highly sensitive OncoBEAM RAS assay, an enhanced ...

Technische Universität München

Finding cortisone alternatives with fewer side effects

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 8161 5403 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/die-tum/aktuelles/pressemitteilungen/details/36207/ Images for journalists: https://mediatum.ub.tum.de/1559845 NEWS RELEASE DNA binding is essential for effectiveness of steroids Finding cortisone alternatives with fewer side effects Many people use ...

Sysmex Inostics GmbH

Sysmex Inostics' OncoBEAMTM RAS CRC testing supports clinical outcome improvements for metastatic colorectal cancer patients rechallenged with anti-EGFR therapy

Baltimore, MD (ots) - Sysmex Inostics, Inc., a global leader and pioneer in blood-based circulating tumor DNA (ctDNA) analysis for oncology, today announces the publication of a clinical study evaluating RAS mutation status in circulating tumor DNA (ctDNA) of colorectal cancer (CRC) patients undergoing anti-EGFR ...

Fördergesellschaft IZB mbH

KOPIE VON: Inspirational talks form SIRION Biotech, CLS Behring and the German Accelerator at the 13th Biotech Press Lounge at the IZB

Sysmex Inostics GmbH

Sysmex-Inostics Colorectal Cancer Blood-Based OncoBEAMTM RAS CE-IVD Test Shows Concordance with Standard of Care Tissue-Based RAS Testing

Baltimore, Maryland (ots) - Sysmex-Inostics, Inc., a global leader and pioneer in blood-based circulating tumor DNA (ctDNA) analysis for oncology, today announces the publication of a clinical study evaluating the performance of plasma RAS mutation testing with OncoBEAM RAS CRC as compared to standard of care ...

Versameb AG

Versameb raises CHF 6 million and strengthens team to advance its VERSagile technology platform towards clinical trials

Basel, Switzerland (ots) - Versameb AG, a biopharmaceutical company developing innovative ribonucleic acid (RNA) therapeutics, announced today the closing of a CHF 6 million seed financing round. Versameb further strengthens its team by the appointment of Dr. Klaas P. Zuideveld as Chief Development Officer effective ...

Dr. Rath Education Services BV

Micronutrient Combination Suppresses Cell 'Entry Door' For Coronavirus

IgNova GmbH

IgNova files patent application on antibody against COVID-19

Visbek, Germany (ots) - IgNova announced today that it has filed a patent application covering the use of passive immunization to control SARS-CoV-2 infection in humans. IgNova, a biopharmaceutical R&D start up, researches technology based on specific egg immunoglobulins (IgY). The patented IgY binds the spike protein of SARS-CoV-2, neutralizing the virus when it enters the mouth or nose and, therefore, inhibiting the ...

eleva GmbH

Eleva's drug candidate to be examined for use in Covid-19 treatment

Freiburg (ots) - Eleva, a manufacturer of superior biologics, is exploring the potential of one of its drug candidates for first-in-line therapy of Covid-19. The compound, factor H, is part of the complement system, which is believed to affect the severity of the course of Covid-19. Eleva has developed factor H previously for a different indication and taken it through ...

Technische Universität München

A disease trigger for pancreatitis has been identified

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 8161/ 71-5403 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36036/ High resolution images: https://mediatum.ub.tum.de/1545776 NEWS RELEASE A Calcium channel is involved in the development of pancreatitis A disease trigger for pancreatitis has been identified One factor ...

Technische Universität München

In the hunt for new treatments against the coronavirus

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 8161/ 71-3207 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/35999/ High resolution images: https://mediatum.ub.tum.de/1544195 In the hunt for new treatments against the coronavirus Researchers develop software for drug repurposing Currently, the corona pandemic is ...

Technische Universität München

Crohn's disease: Preserving inflammation-free phases

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 8161/ 71-5403 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/35979/ High resolution images: https://mediatum.ub.tum.de/1543290 NEWS RELEASE Early detection of Crohn’s disease flare-ups leads to improved therapy options Preserving inflammation-free phases Crohn’s ...

Technische Universität München

A molecular map for the plant sciences

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 8161/ 71-5403 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/ High resolution images: https://mediatum.ub.tum.de/1540641 NEWS RELEASE First comprehensive map of the proteome of the model plant Arabidopsis thaliana A molecular map for the plant sciences Plants are essential for ...

Technische Universität München

Fatal overproduction of antibodies: Mutations in plasma cells play a key role in light chain amyloidosis

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 10510 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/35938/ High resolution images: https://mediatum.ub.tum.de/1540362 NEWS RELEASE Fatal overproduction of ...

Sysmex Inostics GmbH

Sysmex Inostics' updated SafeSEQ Breast Cancer Panel advances novel clinical uses of ctDNA through quantitative testing

Baltimore, Maryland (ots) - Building on the ultra-high sensitivity SafeSEQ Breast Cancer Panel circulating tumor DNA (ctDNA) test launched at the American Association of Cancer Research 2019 annual meeting, Sysmex Inostics has updated the test to provide additional key information for investigation of the validity ...

Technische Universität München

The secret of color adaption in fish and amphibians unveiled: Transport proteins can switch between microtubule network and actin network

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 10510 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/35911/ High resolution images: https://mediatum.ub.tum.de/1538032 NEWS RELEASE Lane change in the ...